5 analysts have expressed quite a lot of opinions on Precise Sciences EXAS over the previous quarter, providing a various set of opinions from bullish to bearish.
Summarizing their current assessments, the desk under illustrates the evolving sentiments prior to now 30 days and compares them to the previous months.
| Bullish | Considerably Bullish | Detached | Considerably Bearish | Bearish | |
|---|---|---|---|---|---|
| Complete Scores | 5 | 0 | 0 | 0 | 0 |
| Final 30D | 1 | 0 | 0 | 0 | 0 |
| 1M In the past | 0 | 0 | 0 | 0 | 0 |
| 2M In the past | 3 | 0 | 0 | 0 | 0 |
| 3M In the past | 1 | 0 | 0 | 0 | 0 |
Within the evaluation of 12-month value targets, analysts unveil insights for Precise Sciences, presenting a mean goal of $83.0, a excessive estimate of $100.00, and a low estimate of $70.00. A damaging shift in sentiment is obvious as analysts have decreased the common value goal by 6.48%.
Exploring Analyst Scores: An In-Depth Overview
A complete examination of how monetary specialists understand Precise Sciences is derived from current analyst actions. The next is an in depth abstract of key analysts, their current evaluations, and changes to scores and value targets.
| Analyst | Analyst Agency | Motion Taken | Score | Present Worth Goal | Prior Worth Goal |
|---|---|---|---|---|---|
| Mark Massaro | BTIG | Lowers | Purchase | $70.00 | $80.00 |
| Mark Massaro | BTIG | Lowers | Purchase | $80.00 | $85.00 |
| Kyle Mikson | Canaccord Genuity | Lowers | Purchase | $85.00 | $90.00 |
| Patrick Donnelly | Citigroup | Lowers | Purchase | $80.00 | $100.00 |
| Patrick Donnelly | Citigroup | Broadcasts | Purchase | $100.00 | – |
Key Insights:
- Motion Taken: Analysts steadily replace their suggestions primarily based on evolving market situations and firm efficiency. Whether or not they ‘Preserve’, ‘Elevate’ or ‘Decrease’ their stance, it displays their response to current developments associated to Precise Sciences. This info offers a snapshot of how analysts understand the present state of the corporate.
- Score: Analysts assign qualitative assessments to shares, starting from ‘Outperform’ to ‘Underperform’. These scores convey the analysts’ expectations for the relative efficiency of Precise Sciences in comparison with the broader market.
- Worth Targets: Analysts navigate by way of changes in value targets, offering estimates for Precise Sciences’s future worth. Evaluating present and prior targets gives insights into analysts’ evolving expectations.
Navigating by way of these analyst evaluations alongside different monetary indicators can contribute to a holistic understanding of Precise Sciences’s market standing. Keep knowledgeable and make data-driven choices with our Scores Desk.
Keep updated on Precise Sciences analyst scores.
Get to Know Precise Sciences Higher
Precise Sciences Company, headquartered in Madison, Wisconsin, offers most cancers screening and diagnostic take a look at merchandise in the US and internationally. Precise’s Cologuard screening take a look at, a noninvasive stool-based DNA take a look at, is a pre-cancer screening take a look at for colorectal most cancers. The corporate additionally competes within the precision oncology market with Oncotype DX, a collection of tissue-based genomic exams for estimating recurrence danger and probability of profit from chemotherapy for breast and colon most cancers, and OncoExTra, a liquid-based complete genomic profiling take a look at. It’s creating liquid biopsy exams for molecular residual illness, colorectal most cancers screening, and multicancer screening, too.
Monetary Insights: Precise Sciences
Market Capitalization Evaluation: Falling under business benchmarks, the corporate’s market capitalization displays a decreased measurement in comparison with friends. This positioning could also be influenced by components similar to progress expectations or operational capability.
Income Development: Precise Sciences displayed optimistic leads to 3 months. As of 31 March, 2024, the corporate achieved a strong income progress price of roughly 5.82%. This means a notable improve within the firm’s top-line earnings. As in comparison with rivals, the corporate encountered difficulties, with a progress price decrease than the common amongst friends within the Well being Care sector.
Web Margin: Precise Sciences’s internet margin surpasses business requirements, highlighting the corporate’s distinctive monetary efficiency. With a formidable -17.29% internet margin, the corporate successfully manages prices and achieves robust profitability.
Return on Fairness (ROE): Precise Sciences’s ROE lags behind business averages, suggesting challenges in maximizing returns on fairness capital. With an ROE of -3.51%, the corporate might face hurdles in attaining optimum monetary efficiency.
Return on Belongings (ROA): Precise Sciences’s ROA is under business averages, indicating potential challenges in effectively using belongings. With an ROA of -1.72%, the corporate might face hurdles in attaining optimum monetary returns.
Debt Administration: Precise Sciences’s debt-to-equity ratio is under the business common. With a ratio of 0.82, the corporate depends much less on debt financing, sustaining a more healthy steadiness between debt and fairness, which might be considered positively by buyers.
The Significance of Analyst Scores Defined
Consultants in banking and monetary techniques, analysts specialise in reporting for particular shares or outlined sectors. Their complete analysis entails attending firm convention calls and conferences, analyzing monetary statements, and fascinating with insiders to generate what are generally known as analyst scores for shares. Sometimes, analysts assess and price every inventory as soon as per quarter.
Past their normal evaluations, some analysts contribute predictions for metrics like progress estimates, earnings, and income, furnishing buyers with further steerage. Customers of analyst scores must be conscious that this specialised recommendation is formed by human views and could also be topic to variability.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
